Cargando…
Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinoma
BACKGROUND: Autophagy, a key regulator of programmed cell death, is critical for maintaining the stability of the intracellular environment. Increasing evidence has revealed the clinical importance of interactions between autophagy and immune status in lung adenocarcinoma. The present study evaluate...
Autores principales: | Li, Qiaxuan, Xie, Daipeng, Yao, Lintong, Qiu, Hongrui, You, Peimeng, Deng, Jialong, Li, Congsen, Zhan, Weijie, Weng, Maotao, Wu, Shaowei, Li, Fasheng, Zhou, Yubo, Zeng, Fanjun, Zheng, Yong, Zhou, Haiyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513242/ https://www.ncbi.nlm.nih.gov/pubmed/36177001 http://dx.doi.org/10.3389/fimmu.2022.944378 |
Ejemplares similares
-
Identification of Prognostic Model Based on Immune-Related LncRNAs in Stage I-III Non-Small Cell Lung Cancer
por: Li, Qiaxuan, et al.
Publicado: (2021) -
Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB–IV NSCLC (LCDigital-IO Study): a multicenter retrospective study
por: Wu, Shaowei, et al.
Publicado: (2023) -
A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy
por: Xu, Bin, et al.
Publicado: (2023) -
Homologous recombination repair rathway and RAD54L in early-stage lung adenocarcinoma
por: Zheng, Shaopeng, et al.
Publicado: (2021) -
KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials
por: Zhu, Hongyuan, et al.
Publicado: (2021)